4//SEC Filing
SMITH IAN F 4
Accession 0000950170-25-003052
CIK 0001707502other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:28 PM ET
Size
12.0 KB
Accession
0000950170-25-003052
Insider Transaction Report
Form 4
SMITH IAN F
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-01-03−3,255→ 0 total→ Common Stock (3,255 underlying) - Award
Stock Option (Right to Buy)
2025-01-06+22,148→ 22,148 totalExercise: $4.10Exp: 2035-01-06→ Common Stock (22,148 underlying) - Award
Restricted Stock Units
2025-01-06+18,293→ 18,293 total→ Common Stock (18,293 underlying) - Exercise/Conversion
Common Stock
2025-01-03+3,255→ 112,972 total
Footnotes (4)
- [F1]Restricted stock units convert to common stock on a one-for-one basis.
- [F2]The restricted stock units were granted on January 3, 2024 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant.
- [F3]The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the "Smith Equity Awards") were granted on January 6, 2025 ("the Grant Date") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Second Amendment to Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full.
- [F4]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "Smith RSUs").
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001197032
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 5:28 PM ET
- Size
- 12.0 KB